JP2013500739A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500739A5
JP2013500739A5 JP2012523432A JP2012523432A JP2013500739A5 JP 2013500739 A5 JP2013500739 A5 JP 2013500739A5 JP 2012523432 A JP2012523432 A JP 2012523432A JP 2012523432 A JP2012523432 A JP 2012523432A JP 2013500739 A5 JP2013500739 A5 JP 2013500739A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleic acid
antibody
disease
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012523432A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500739A (ja
Filing date
Publication date
Priority claimed from IL200202A external-priority patent/IL200202A0/en
Application filed filed Critical
Publication of JP2013500739A publication Critical patent/JP2013500739A/ja
Publication of JP2013500739A5 publication Critical patent/JP2013500739A5/ja
Pending legal-status Critical Current

Links

JP2012523432A 2009-08-02 2010-08-02 新規タンパク質 Pending JP2013500739A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL200202A IL200202A0 (en) 2009-08-02 2009-08-02 Novel proteins
IL200202 2009-08-02
PCT/IL2010/000621 WO2011016026A2 (en) 2009-08-02 2010-08-02 Novel proteins

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2015047903A Division JP5833780B2 (ja) 2009-08-02 2015-03-11 新規タンパク質
JP2015155720A Division JP2015212302A (ja) 2009-08-02 2015-08-06 新規タンパク質

Publications (2)

Publication Number Publication Date
JP2013500739A JP2013500739A (ja) 2013-01-10
JP2013500739A5 true JP2013500739A5 (enExample) 2013-09-12

Family

ID=42263570

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012523432A Pending JP2013500739A (ja) 2009-08-02 2010-08-02 新規タンパク質
JP2015047903A Expired - Fee Related JP5833780B2 (ja) 2009-08-02 2015-03-11 新規タンパク質
JP2015155720A Pending JP2015212302A (ja) 2009-08-02 2015-08-06 新規タンパク質

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015047903A Expired - Fee Related JP5833780B2 (ja) 2009-08-02 2015-03-11 新規タンパク質
JP2015155720A Pending JP2015212302A (ja) 2009-08-02 2015-08-06 新規タンパク質

Country Status (11)

Country Link
US (1) US8647632B2 (enExample)
EP (2) EP2461829B1 (enExample)
JP (3) JP2013500739A (enExample)
KR (1) KR101623355B1 (enExample)
CN (1) CN102596247B (enExample)
AU (1) AU2010280368B2 (enExample)
CA (1) CA2769001C (enExample)
IL (3) IL200202A0 (enExample)
IN (1) IN2012DN00879A (enExample)
SG (2) SG178097A1 (enExample)
WO (1) WO2011016026A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2742061A4 (en) * 2011-08-08 2015-05-27 Two To Biotech Ltd NOVEL PEPTIDES, COMPOSITIONS COMPRISING THEM AND USES THEREOF IN METHODS FOR THE TREATMENT OF METABOLIC, CARDIAC AND IMMUNE DISORDERS
CN105916874A (zh) * 2014-01-02 2016-08-31 两合生物科技有限公司 新型多肽
CN104262468B (zh) * 2014-09-28 2017-01-18 新乡医学院 一种葡萄糖转运蛋白抑制多肽及其制备方法、应用
TWI604888B (zh) 2015-03-05 2017-11-11 積水特殊化學美國有限責任公司 用於氯乙烯單體(vcm)聚合之聚乙烯醇(pvoh)分散劑
KR102713301B1 (ko) 2015-12-11 2024-10-02 고쿠리츠다이가쿠호진 고치다이가쿠 췌장암 및 췌장관 내 유두상 점액성 종양의 마커

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5286846A (en) 1991-06-14 1994-02-15 The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US6551795B1 (en) 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
AU2001261513A1 (en) * 2000-05-15 2001-11-26 Braswell, Glenn A. Composition and method for increasing testosterone levels
US6566333B2 (en) 2000-06-19 2003-05-20 Uab Research Foundation Osteoclast secreted chemokine and uses thereof
AU2003900747A0 (en) * 2003-02-18 2003-03-06 Garvan Institute Of Medical Research Diagnosis and treatment of pancreatic cancer
WO2006042002A2 (en) 2004-10-05 2006-04-20 Oregon Health And Science University Compositions and methods for treating disease
US20080248134A1 (en) 2005-05-04 2008-10-09 Auckland Uniservices Limited Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof
EP2097538A4 (en) * 2006-12-07 2011-11-30 Switchgear Genomics TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS

Similar Documents

Publication Publication Date Title
Liu et al. The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis
AU2014317035B2 (en) IL-18 binding protein (IL-18BP) in inflammatory diseases
US12173055B2 (en) N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
Cavone et al. Increase in the level of proinflammatory cytokine HMGB1 in nasal fluids of patients with rhinitis and its sequestration by glycyrrhizin induces eosinophil cell death
CN106164675B (zh) 检测人类骨膜蛋白的新型测定
WO2016141334A2 (en) Compositions and methods for diagnosing and treating autoimmune diseases
AU2024284360A1 (en) Tnf inhibitor combination therapies
EP4007772A1 (en) Antibodies to candida and uses thereof
EP2838559B1 (en) Combination therapy of anti-mif antibodies and glucocorticoids
WO2022196816A1 (ja) 急性肺障害および肺線維症の急性増悪を改善するための医薬組成物
WO2014165866A2 (en) Methods for immune-based diagnosis, prevention and personalized treatment of narcolepsy
WO2011038689A1 (zh) 人类新细胞因子VSTM1-v2及其应用
Gao et al. Fungal commensal promotes intestinal repair via its secreted peptide in mice
CN102307894B (zh) 螨过敏原之变体及其用途
CN103344764B (zh) 胰高血糖素样肽-1生物学活性检测试剂及检测方法和试剂盒
CN119390843A (zh) 抗tl1a抗体及其制备方法和应用
Matsuno et al. Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry
CN106810603B (zh) 一种多肽及其应用
EP2665746B1 (en) Antibodies against the s100p protein for the treatment and diagnosis of cancer
KR20170098941A (ko) 인간 dpp-4를 검출하기 위한 검정법
EP4130035A1 (en) Antibody and fusion protein for treating coronaviruses and use thereof
WO2014181273A1 (en) Methods for treating inflammatory bowel disease
US20230416381A1 (en) Methods for treating or preventing acute respiratory distress syndrome
EP4573121A1 (en) Method of selecting patients for treatment with an il-33 axis antagonist
Qi et al. The involvement of proline-rich protein Mus musculus predicted gene 4736 in ocular surface functions